MYGN Myriad Genetics, Inc.
Healthcare$3.82-2.30%ClosedMarket Cap: $360.8M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$6.00
Target (Median)
$6.00
Target Range
$6.00 - $6.00
Upside from current price: 57.1%
Rating Distribution
1 Strong Buy1 Buy7 Hold1 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-05-06 | TD Cowen | maintain | Hold | Hold |
| 2026-02-24 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-02-24 | UBS | maintain | Neutral | Neutral |
| 2025-11-11 | Piper Sandler | maintain | Overweight | Overweight |
| 2025-11-05 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2025-11-04 | UBS | maintain | Neutral | Neutral |
| 2025-11-04 | TD Cowen | maintain | Hold | Hold |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.16 | $911.6M | 5 |
| Sun Dec 31 | $0.29 | $965.2M | 2 |
| Mon Dec 31 | $0.55 | $1.04B | 1 |
| Tue Dec 31 | $0.65 | $1.05B | 1 |